Logo IMG
HOME > My Amsci > Restricted Access

Restricted Access The content you've requested is available without charge only to active Sigma Xi members and American Scientist subscribers.

If you are an active member or an individual subscriber, please log in now in order to access this article.

If you are not a member or individual subscriber, you can:


Figure 5. As of December 2000, tandem mass spectrometry . . .Click to Enlarge Image

A large number of rare diseases result from the loss of critical enzymes, allowing toxic metabolic by-products to build up in the body. In essence, an afflicted person is poisoned, and the results can be devastating: severe neurological impairment, sometimes death. Yet in many cases, simple changes in the diet can avert all harm. The best time to obtain a diagnosis is before the onset of any symptoms—ideally within a week of birth. All U.S. states and many nations require that all newborns be screened for a spectrum of inherited disease. Until recently, states screened for only a handful of diseases, each requiring a unique test, but refinements in tandem mass spectrometry techniques are now allowing states to screen for more than two dozen diseases with a single test. A growing number of states are using tandem mass spectrometry for efficient newborn screening.

Connect With Us:


Subscribe to Free eNewsletters!

Read Past Issues on JSTOR

JSTOR, the online academic archive, contains complete back issues of American Scientist from 1913 (known then as the Sigma Xi Quarterly) through 2005.

The table of contents for each issue is freely available to all users; those with institutional access can read each complete issue.

View the full collection here.

RSS Feed Subscription

Receive notification when new content is posted from the entire website, or choose from the customized feeds available.

Write for American Scientist

Review our submission guidelines.

Subscribe to American Scientist